Our Commitment
Precision Therapeutics is dedicated to the individualization of cancer treatment and the development and delivery of treatment support tools and services that assist physicians and benefit cancer patients.
Introducing a way to help treat
cancer without a single patient side effect.
And even more amazingly, without a single patient.
With the ChemoFx
® Drug Response Marker, you can determine how chemotherapy will impact cancer cells before it impacts cancer patients. This simple test determines how a patient’s particular cells respond to different chemotherapies in the lab—not in the patient.